Kaplan–Meier analysis showed that a higher level of DGCR5 was likely to be poor 2-year disease-free survival (DFS) rate for ESCC patients (Fig. 1D), suggesting that elevated DGCR5 was correlated with poor prognosis. This evidence concerns the gene DGCR5 and esophageal squamous cell carcinoma.